[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic

Momoyo Omata1, Masafumi Fukagawa, Takatoshi Kakuta

  • 1Department of Internal Medicine, Hachioji Azumacho Clinic, Tokyo, Japan.

Clinical Calcium
|May 1, 2015
PubMed

Insights

Chronic kidney disease-mineral and bone disorder (CKD-MBD) involves bone and vascular issues, increasing cardiovascular mortality risk. Early intervention targeting FGF23 and phosphate is crucial for better CKD patient outcomes.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a progressive condition impacting bone health and vasculature.
  • Vascular calcification in CKD patients is a significant contributor to cardiovascular disease and mortality.
  • Elevated FGF23 levels are linked to increased mortality, vascular calcification, and CKD progression.

Purpose of the Study:

  • To highlight the critical role of CKD-MBD in cardiovascular complications.
  • To emphasize the association between FGF23, vascular calcification, and mortality in CKD.
  • To underscore the necessity of early therapeutic interventions for CKD-MBD.

Main Methods:

  • Literature review of studies investigating CKD-MBD pathophysiology.
  • Analysis of the relationship between serum FGF23, klotho, phosphate, and PTH levels in early CKD.
  • Examination of the impact of vascular calcification on cardiovascular outcomes in dialysis patients.

Main Results:

  • CKD-MBD encompasses laboratory, bone, and vascular abnormalities.
  • Cardiovascular disease accounts for over 40% of deaths in dialysis patients, linked to arteriosclerosis and vascular calcification.
  • Despite normal phosphate levels in early CKD due to FGF23 and PTH upregulation, renal insufficiency reduces klotho.

Conclusions:

  • Vascular calcification is a key pathophysiological mechanism driving cardiovascular disease and mortality in CKD patients.
  • Serum FGF23 concentration is a significant predictor of mortality, vascular calcification, and CKD progression.
  • Early management of CKD-MBD is essential to improve patient prognosis and mitigate cardiovascular risks.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
1.0K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
645
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
764